Importer of Controlled Substances; Notice of Application, 33475-33476 [E9-16520]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 132 / Monday, July 13, 2009 / Notices
DEPARTMENT OF JUSTICE
mstockstill on DSKH9S0YB1PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
Notice is hereby given that on June
25, 2009, a proposed Consent Decree
(‘‘Decree’’) in United States v. Holcim
(US) Inc., Civil Action No. 2:09–cv–
12526–LPZ–DAS, was lodged with the
United States District Court for the
Eastern District of Michigan.
In this action the United States seeks
to address violations of the Clean Air
Act at a Portland cement manufacturing
facility owned and operated by the
Defendant, Holcim (US) Inc., in Dundee,
Michigan. The violations, which
occurred numerous times for several
years, involved emissions from the main
stack for two kilns which exceeded 15%
opacity and the baghouse inlet
temperatures for each kiln exceeding its
limitation.
During the course of settlement
negotiations with the Department of
Justice, the Defendant on November 11,
2008 announced that it must reduce
production capacity in its cement
operations in response to the extensive
downturn in the demand for cement
products and stated it would
permanently close the Dundee facility.
The Defendant permanently shut down
its two kilns at the Dundee facility, one
kiln on November 30, 2008 and the
other kiln on March 14, 2009.
The proposed Decree resolves the
Defendant’s violations by implementing
injunctive relief which will ensure, if
operating the kilns at the Dundee
facility, the Defendant will not exceed
the opacity limitation at the main stack
and will not exceed the applicable
baghouse inlet temperature for the kilns.
Additionally, the Defendant has
reporting, notification and approval
requirements under the Decree to the
U.S. Environmental Protection Agency
(‘‘EPA’’) and the Michigan Department
of Environmental Quality (‘‘MDEQ’’),
which includes seeking permission and
receiving approval from EPA and MDEQ
to re-start a permanently closed kiln.
The proposed Decree also requires
payment of a civil penalty in the
amount of $159,607.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the proposed Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
VerDate Nov<24>2008
18:36 Jul 10, 2009
Jkt 217001
20044–7611, and should refer to United
States v. Holcim (US) Inc., D.J. Ref. No.
90–5–2–1–09594.
The proposed Decree may be
examined at the Office of the United
States Attorney, 211 W. Fort Street,
Suite 2001, Detroit, Michigan 48226,
and at U.S. EPA Region 5, 77 W. Jackson
Blvd., 16th Floor (EPA Library),
Chicago, Illinois 60604. During the
public comment period, the proposed
Decree may also be examined on the
following Department of Justice Web
site https://www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
proposed Decree may also be obtained
by mail from the Consent Decree
Library, P.O. Box 7611, U.S. Department
of Justice, Washington, DC 20044–7611
or by faxing or e-mailing a request to
Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$11.00 (25 cents per page reproduction
cost) payable to the U.S. Treasury or, if
by e-mail or fax, forward a check in that
amount to the Consent Decree Library at
the stated address.
Maureen Katz,
Assistant Chief Environmental Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. E9–16412 Filed 7–10–09; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms
and Explosives
[Docket No. ATF 32N; ATF O 1120.8]
Delegation Order—Authority To
Facilitate Implementation of the NICS
Improvement Amendments Act of 2007
1. Purpose. This order delegates the
authority to exercise the authorities and
responsibilities committed to the
Director of the Bureau of Alcohol,
Tobacco, Firearms and Explosives (ATF)
under the NICS Improvement
Amendments Act of 2007, Public Law
110–180 (NIAA). This authority is to
establish and enforce the criteria that
applicable Federal departments and
agencies and states use to create
qualifying relief from firearms
disabilities programs, to make decisions
as to whether applicable Federal
departments and agencies and states
have properly implemented and
certified relief from firearms disabilities
programs under the NIAA, and to make
any related determinations under the
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
33475
NIAA regarding such relief from
firearms disabilities programs.
2. Delegations. Under the authority
vested in the Director, Bureau of
Alcohol, Tobacco, Firearms and
Explosives, by Title 28 U.S.C. 599A, 28
CFR 0.130–0.133, and Attorney General
Order Number 3072–2009, Delegation of
Authority to the Director of the Bureau
of Alcohol, Tobacco, Firearms, and
Explosives to Facilitate Implementation
of the NICS Improvement Amendments
of 2007, I hereby delegate to the
Assistant Director, Enforcement
Programs and Services, the authority to
exercise the authorities and
responsibilities committed to the
Director of ATF under the NIAA. This
authority is to establish and enforce the
criteria that applicable Federal
departments and agencies and states use
to create qualifying relief from firearms
disabilities programs, to make decisions
as to whether applicable Federal
departments and agencies and states
have properly implemented and
certified relief from firearms disabilities
programs under the NIAA, and to make
any related determinations under the
NIAA regarding such relief from
firearms disabilities programs.
3. Redelegation. The authority in this
order may be redelegated to a position
not lower than the Chief, Firearms
Programs Division.
4. Questions. Questions regarding this
order should be addressed to the Chief,
Firearms Programs Division at (202)
648–7090.
Signed: June 22, 2009.
Kenneth Melson,
Acting Director.
[FR Doc. E9–16453 Filed 7–10–09; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title
21, Code of Federal Regulations (CFR),
1301.34(a), this is notice that on June
16, 2009, Noramco, Inc., Division of
Ortho-McNeil, Inc., 500 Swedes
E:\FR\FM\13JYN1.SGM
13JYN1
33476
Federal Register / Vol. 74, No. 132 / Monday, July 13, 2009 / Notices
Landing Road, Wilmington, Delaware
19801, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Thebaine (9333), a basic class of
controlled substance listed in schedule
II.
The company plans to import a
Thebaine derivative for the bulk
manufacture of controlled substances
for their customers. The company will
also import analytical reference
standards for distribution to their
customers for research purposes.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
being should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than August 12, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–16520 Filed 7–10–09; 8:45 am]
mstockstill on DSKH9S0YB1PROD with NOTICES
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
VerDate Nov<24>2008
18:36 Jul 10, 2009
Jkt 217001
this is notice that on May 20, 2009,
Organix Inc., 240 Salem Street, Woburn,
Massachusetts 01801, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Marihuana
(7360), a basic class of controlled
substance listed in schedule I.
The company plans to manufacture a
synthetic cannabinol in bulk for sale to
its customers for research purposes. No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 11, 2009.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–16521 Filed 7–10–09; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (09–066)]
Review of U.S. Human Space Flight
Plans Committee; Meeting
AGENCY: National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
SUMMARY: In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
announces a meeting of the Review of
U.S. Human Space Flight Plans
Committee. The agenda topics for the
meeting include:
• Kennedy Space Center Perspective.
• Constellation projects.
• Committee subgroup report.
• Public comment.
DATES: Thursday, July 30, 2009, 8 a.m.–
4 p.m. Note: All times listed are local
times.
ADDRESSES: Hilton Cocoa Beach
Oceanfront, Grand Ballroom, 1550
North Atlantic Avenue, Cocoa Beach,
Florida 32931, 321–799–0003.
FOR FURTHER INFORMATION CONTACT: Mr.
Philip R. McAlister, Office of Program
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Analysis and Evaluation, National
Aeronautics and Space Administration,
Washington, DC 20546. Phone 202–358–
0712.
The
meeting will be open to the public up
to the seating capacity of the room. It is
imperative that the meeting be held on
this date to accommodate the
scheduling priorities of the key
participants.
SUPPLEMENTARY INFORMATION:
P. Diane Rausch,
Advisory Committee Management Officer,
National Aeronautics and Space
Administration.
[FR Doc. E9–16533 Filed 7–10–09; 8:45 am]
BILLING CODE P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (09–064)]
Review of U.S. Human Space Flight
Plans Committee; Meeting
AGENCY: National Aeronautics and
Space Administration.
ACTION:
Notice of meeting.
SUMMARY: In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
announces a meeting of the Review of
U.S. Human Space Flight Plans
Committee. The agenda topics for the
meeting include:
• Johnson Space Center Perspective.
• Constellation projects.
• Committee subgroup report.
• Public comment.
DATES: Tuesday, July 28, 2009, 10 a.m.–
4 p.m. Note: All times listed are local
times.
ADDRESSES: South Shore Harbour Resort
& Conference Center, Crystal Ballroom
Salon A & B, 2500 South Shore Blvd.,
League City, TX 77573, 800–442–5005.
FOR FURTHER INFORMATION CONTACT: Mr.
Philip R. McAlister, Office of Program
Analysis and Evaluation, National
Aeronautics and Space Administration,
Washington, DC 20546. Phone 202–358–
0712.
The
meeting will be open to the public up
to the seating capacity of the room. It is
imperative that the meeting be held on
this date to accommodate the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 74, Number 132 (Monday, July 13, 2009)]
[Notices]
[Pages 33475-33476]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16520]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21, Code of Federal Regulations
(CFR), 1301.34(a), this is notice that on June 16, 2009, Noramco, Inc.,
Division of Ortho-McNeil, Inc., 500 Swedes
[[Page 33476]]
Landing Road, Wilmington, Delaware 19801, made application by letter to
the Drug Enforcement Administration (DEA) to be registered as an
importer of Thebaine (9333), a basic class of controlled substance
listed in schedule II.
The company plans to import a Thebaine derivative for the bulk
manufacture of controlled substances for their customers. The company
will also import analytical reference standards for distribution to
their customers for research purposes.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of controlled
substance may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43 and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections being should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, VA 22152; and must be filed no later
than August 12, 2009.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, 40 FR 43745-46), all applicants
for registration to import a basic class of any controlled substances
in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-16520 Filed 7-10-09; 8:45 am]
BILLING CODE 4410-09-P
